This inventor holds 1 USPTO granted patent. Top assignee: Virginia Commonwealth University. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Katherine Belecki: Innovator in Pharmaceutical Synthesis
Introduction
Katherine Belecki is a notable inventor based in Richmond, VA (US). She has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of methods for synthesizing angiotensin II receptor antagonists.
Latest Patents
Katherine holds a patent titled "Convergent approach to the total synthesis of telmisartan via a Suzuki cross-coupling reaction." This patent describes methods for synthesizing telmisartan in high yield and purity. The innovative techniques involve the coupling of two structurally distinct benzimidazole units through a Suzuki cross-coupling reaction. Additionally, the patent provides methods for regioselectively synthesizing one of the benzimidazole units. Katherine has 1 patent to her name.
Career Highlights
Katherine is affiliated with Virginia Commonwealth University, where she contributes to research and development in the pharmaceutical sciences. Her work has implications for improving the efficacy and safety of medications used to treat various conditions.
Collaborations
Katherine has collaborated with esteemed colleagues, including Frank B Gupton and Alex Martin. These partnerships have enhanced her research and expanded the impact of her innovations in the field.
Conclusion
Katherine Belecki is a pioneering inventor whose work in pharmaceutical synthesis is paving the way for advancements in medication development. Her contributions are vital to the ongoing evolution of therapeutic solutions.